SECAUCUS, NJ and TORONTO, ON – Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced the completion of its acquisition of LifeLabs from OMERS. The transaction, valued at approximately CAN $1.35… Read More
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial carcinoma and susceptible FGFR3 alterations Approval based on THOR results, showing 36 percent reduction in risk… Read More
Keeping up to date on recommended vaccinations helps reduce the risk of severe illness, keeps communities healthy and reduces the burden on our health care system. Community-driven initiatives across Canada… Read More
PADCEV plus pembrolizumab approved based on EV-302 trial KIRKLAND, QC – Pfizer Canada ULC announced that Health Canada has approved PADCEV® (enfortumab vedotin) an antibody-drug conjugate (ADC) in combination with… Read More
Approval is based on the Phase 3 KEYNOTE-A39 trial KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted… Read More
